Vimarsana
Biggest News Aggregation in the World

Donor Origin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Donor Origin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Donor Origin Today - Breaking & Trending Today

Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting - Vimarsana News

Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting

Published: September 28, 2023

Gamida Cell Ltd. , a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that it will be presenting at the Society for Immunotherapy of Cancer’s 38th Annual...

Source: marketscreener.com
Related Topics:
San DiegoUnited StatesAvner YeffetDima YackoubovSociety For Immunotherapy Of CancerGamida Cell LtdExchange CommissionGamida Cell IncGamida CellAnnual MeetingExhibit HallsSafety InformationHost DiseaseDonor OriginSerious InfectionsPrescribing InformationQuality AssuranceRare Genetic DiseasesPrivate Securities Litigation Reform ActRisk FactorsQuarterly Report
Gamida Cell's Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval - Vimarsana News

Gamida Cell's Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval

Published: April 17, 2023

Omisirge is approved by the FDA as a new donor source for allogeneic stem cell transplant Global, randomized Phase 3 clinical trial showed faster neutrophil recovery and reduced bacterial and... | April 17, 2023

Source: marketscreener.com
Related Topics:
United StatesKiryat GatAbbey JenkinsStevenm DevineExchange CommissionGamida Cell LtdNational Marrow Donor ProgramDrug AdministrationMoelis CompanyAmerican Society Of HematologyGamida CellPrescribing InformationChief Executive OfficerAmerican SocietyOmisirge PhaseChief Medical OfficerNational Marrow DonorAfrican AmericanCell AssistOmisirge TuesdaySafety InformationHost DiseaseDonor OriginSerious InfectionsQuality Assurance